Therapies utilizing stem cells isolated from various tissues are currently undergoing clinical evaluation. It is predicted that for many indications large quantities of cells will be required to treat the numbers of patients in need of therapy. This requirement represents a challenge because the surface area needed to generate the projected numbers of cells is significant. Microcarriers are a viable platform to meet the surface area requirement for generation of the predicted number of cells. One challenge when transitioning to larger reactors is the identification of agitation conditions that allow for good suspension of the microcarriers and sufficient kLa and nutrient mixing, without causing mechanical or shear damage to the attached cel...
Improvements to process development technology will have a significant impact in reducing the overal...
Microcarriers have been widely used for various biotechnology applications because of their high sca...
Renewed interest in microcarrier-based processes for the large-scale culture of adherent cells for v...
Industry trends in regenerative medicine show an increased need for scalable and closed manufacturin...
Two dimensional (2-D) cell culture technologies have proven inadequate for large scale manufacturing...
Culture parameters including type of matrix, feeding regimes and media formulations have to be fine-...
A scalable biomanufacturing platform is crucial to meet the anticipated demands for off-the-shelf ce...
The potential of human mesenchymal stem cells (hMSCs) for allogeneic cell therapies has created a la...
Industry trends in regenerative medicine highlight a critical need for closed, single use cell cultu...
Allogeneic cell therapies require the manufacture of large amounts of cells in a reliable and robust...
Allogeneic cell therapy products have enormous potential to treat a wide range of unmet medical need...
With recent advances in biotechnology, there is a strong and urgent need for robust platforms to cul...
Human mesenchymal stem cells (hMSCs) isolated from various tissues represent the most highly utilize...
The potential of human mesenchymal stem cells (hMSCs) for allogeneic cell therapies has created a la...
Improvements to process development technology will have a significant impact in reducing the overal...
Improvements to process development technology will have a significant impact in reducing the overal...
Microcarriers have been widely used for various biotechnology applications because of their high sca...
Renewed interest in microcarrier-based processes for the large-scale culture of adherent cells for v...
Industry trends in regenerative medicine show an increased need for scalable and closed manufacturin...
Two dimensional (2-D) cell culture technologies have proven inadequate for large scale manufacturing...
Culture parameters including type of matrix, feeding regimes and media formulations have to be fine-...
A scalable biomanufacturing platform is crucial to meet the anticipated demands for off-the-shelf ce...
The potential of human mesenchymal stem cells (hMSCs) for allogeneic cell therapies has created a la...
Industry trends in regenerative medicine highlight a critical need for closed, single use cell cultu...
Allogeneic cell therapies require the manufacture of large amounts of cells in a reliable and robust...
Allogeneic cell therapy products have enormous potential to treat a wide range of unmet medical need...
With recent advances in biotechnology, there is a strong and urgent need for robust platforms to cul...
Human mesenchymal stem cells (hMSCs) isolated from various tissues represent the most highly utilize...
The potential of human mesenchymal stem cells (hMSCs) for allogeneic cell therapies has created a la...
Improvements to process development technology will have a significant impact in reducing the overal...
Improvements to process development technology will have a significant impact in reducing the overal...
Microcarriers have been widely used for various biotechnology applications because of their high sca...
Renewed interest in microcarrier-based processes for the large-scale culture of adherent cells for v...